Literature DB >> 19444144

Single-stage open reduction, Salter innominate osteotomy, and proximal femoral osteotomy for the management of developmental dysplasia of the hip in children between the ages of 2 and 4 years.

Mohamed M H El-Sayed1.   

Abstract

The management of neglected developmental dysplasia of the hip in walking children has always been a challenge to orthopedic surgeons. The aim of this study was to access the early clinical and radiographic results of surgical treatment of such cases using one-stage open reduction, Salter innominate osteotomy, and proximal femoral osteotomy. Seventy-one surgeries were performed in 55 patients. Favorable clinical and radiographic outcomes were comparable to other studies. We concluded that this single-stage surgery is a technically demanding, but satisfactory procedure in the management of neglected developmental dysplasia of the hip patients, and when performed adequately in indicated patients in specialized centers, it is expected to give good short-term results.

Entities:  

Mesh:

Year:  2009        PMID: 19444144     DOI: 10.1097/BPB.0b013e32832bf618

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  11 in total

Review 1.  How Does Bony Surgery Affect Results of Anterior Open Reduction in Walking-age Children With Developmental Hip Dysplasia?

Authors:  Alpesh Kothari; George Grammatopoulos; Sally Hopewell; Tim Theologis
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

2.  Treatment of adolescents with a periacetabular osteotomy after previous pelvic surgery.

Authors:  Adriana De La Rocha; Daniel J Sucato; Kirsten Tulchin; David A Podeszwa
Journal:  Clin Orthop Relat Res       Date:  2012-03-29       Impact factor: 4.176

3.  The effect of Dega acetabuloplasty and Salter innominate osteotomy on acetabular remodeling monitored by the acetabular index in walking DDH patients between 2 and 6 years of age: short- to middle-term follow-up.

Authors:  Mohamed El-Sayed; Tarek Ahmed; Sameh Fathy; Hosam Zyton
Journal:  J Child Orthop       Date:  2012-11-28       Impact factor: 1.548

4.  Outcome of one-stage treatment of developmental dysplasia of hip in older children.

Authors:  Basant Kumar Bhuyan
Journal:  Indian J Orthop       Date:  2012-09       Impact factor: 1.251

5.  Developmental dysplasia of the hip.

Authors:  Shahryar Noordin; Masood Umer; Kamran Hafeez; Haq Nawaz
Journal:  Orthop Rev (Pavia)       Date:  2010-09-23

6.  Developmental dysplasia of the hip - angle trends after operation in different age groups.

Authors:  Sonja Milasinovic; Radivoj Brdar; Ivana Petronic; Dejan Nikolic; Dragana Cirovic
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

7.  Dega osteotomy for the management of developmental dysplasia of the hip in children aged 2-8 years: results of 58 consecutive osteotomies after 13-25 years of follow-up.

Authors:  Mohamed M H El-Sayed; Mohamed Hegazy; Nasef M Abdelatif; Mohamed A ElGebeily; Tamer ElSobky; Sean Nader
Journal:  J Child Orthop       Date:  2015-06-23       Impact factor: 1.548

8.  Combined Femoral and Acetabular Osteotomy in Children of Walking Age for Treatment of DDH; A Five Years Follow-Up Report.

Authors:  Mahdi Mazloumi; Farzad Omidi-Kashani; Mohamad Hosein Ebrahimzadeh; Hadi Makhmalbaf; Mohamad Mahdi Hoseinayee
Journal:  Iran J Med Sci       Date:  2015-01

9.  Avascular Necrosis of the Hip Compromises Gait Balance Control in Female Juveniles With Unilateral Developmental Dysplasia Treated in Toddlerhood.

Authors:  Wei-Chun Lee; Pei-An Lee; Tsan-Yang Chen; Yu-Ting Chen; Kuan-Wen Wu; Yu-Lin Tsai; Ting-Ming Wang; Tung-Wu Lu
Journal:  Front Bioeng Biotechnol       Date:  2022-03-24

10.  Presentation and Management of Neglected Developmental Dysplasia of Hip (DDH): 8-years' experience with single stage triple procedure at National Institute of Rehabilitation Medicine, Islamabad, Pakistan.

Authors:  Farid Ullah Khan Zimri; Syed Shujaat Ali Shah; Muhammad Saaiq; Faisal Qayyum; Muhammad Ayaz
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.